Sprout Health review

Sprout Health's weight-care offer needs two budgets: the amount collected for a four-week plan and the larger payment for an annual plan. The lower advertised monthly equivalent belongs to the annual purchase. It does not describe a separately payable monthly subscription. Sprout connects patients with licensed clinicians and dispensing pharmacies and says it is neither a pharmacy nor a manufacturer. Its current weight-care menu names compounded semaglutide and tirzepatide, with prescriptions dependent on clinical assessment. Start with the proposed medicine and compare weight-care programs using the actual commitment, supplied period and support arrangement. A favorable pre-qualification result is not the prescribing decision.

The homepage publishes the four-week charges and full annual payments in separate product cards. It describes the annual plans as renewing every twelve months. The weight-care hero says the visit, medication and shipping are included and advertises the same price at any dose. Those are provider statements about the advertised offer. They do not identify a patient's selected formulation, quantity, assigned pharmacy or any necessary diagnostic work. Each advertised figure belongs to a particular billing term. Ask for the exact bill and supplied treatment period before treating an advertised amount as the complete recurring cost of care.

A recurring billing interval also has to agree with the applicable policy. Sprout's refund page describes monthly, three-month and six-month subscriptions, while the current homepage offers four-week and annual purchasing. Its detailed care guide labels older instructions as legacy material and still describes calendar-date monthly or quarterly renewal. The monthly cost calculator can organize confirmed terms; it cannot decide which agreement governs a purchase. Record the initial collection, next charge date, recurrence and medication supply together. A four-week interval should stay a four-week interval unless the selected agreement explicitly provides a different schedule.

The prepaid plan guide is relevant before accepting the annual offer. Dividing a full payment over twelve months makes it easier to compare budgets, but the money can leave the account at the start of the term. The refund policy says unused medication months may be refunded using the actual amount paid divided by the plan's months. Confirm that this calculation applies to the selected annual plan and how shipments reduce the remaining balance. A patient who changes treatment, moves or decides to leave needs to understand the remaining-term rules. A lower equivalent alone cannot answer those questions.

Medical review and payment are not interchangeable milestones. Sprout says a licensed professional decides whether the requested treatment is appropriate. The terms name MD Integrations and describe synchronous visits in some states. They do not identify the clinician assigned to every member or establish a universal laboratory package. The visit preparation tool can keep questions about monitoring, professional access and the proposed prescription together. Ask which services are included, which require another appointment and whether any separate cost is expected. The company's care page distinguishes administrative support from medical questions, which should go to the responsible clinician.

Availability needs a location-specific answer. The terms exclude six states and list the remaining service areas, but the privacy policy says the platform serves all fifty states. Arkansas also appears in wording about synchronous consultations despite being excluded elsewhere in the terms. These documents do not support an unconditional nationwide claim. Confirm the proposed treatment for the patient's actual address and ask how a change of location affects continued care. The public references also do not establish an insurer-specific medicine benefit. An advertised cash amount or an included consultation should not be read as a coverage determination or a promise about what a health plan will reimburse.

The terms and clinical privacy notice list Foothills Pharmacy and Promise Pharmacy as external contacts. That disclosure does not identify which facility will prepare the selected prescription or independently verify current dispensing authority. The pharmacy verification guide helps organize the actual name, address and questions about the proposed product. Sprout's medication images are illustrative, and its public guides tell patients to verify their prescription and concentration. No dosing calculation should be taken from the pictured vial. A support conversation, a pharmacy assignment and a clinical instruction have different purposes, even when one website coordinates the order.

Sprout's current care page separates its patient app from legacy Medical and Customer Portals. Existing customers are directed to the route in their order confirmation. The legacy refill instructions require a new medical questionnaire and clinician-approved prescription before the next supply can ship. A recurring payment does not establish that those clinical steps are complete. The homepage's estimate for sending prescriptions to a pharmacy and the legacy shipping estimate concern different stages. Neither promises a specific arrival date. Ask when the refill questionnaire becomes available, who reviews it and what happens if assessment or pharmacy processing extends beyond the expected schedule.

Refund eligibility changes at the pharmacy handoff. The policy says a full refund is available before the prescription is sent for fulfillment, even if provider review has occurred. Once it has been sent, the charge is described as nonrefundable, and prescription returns are excluded. That point can arrive before a carrier notification. The program billing checklist should therefore include processing status as well as renewal. Ask how to submit a request and obtain a timestamped acknowledgment. The policy does not promise that every canceled subscription reverses an order already in the pharmacy's hands or refunds treatment that did not produce a desired result.

Stopping the next charge requires notice at least forty-eight hours before its scheduled date under the refund policy. A shipment-delay request needs at least five business days before the scheduled ship date. These are separate deadlines, and the policy says a late cancellation leaves the upcoming charge in place before taking effect in the following cycle. An approved delay resumes billing and shipment on the agreed date. Keep the next charge, intended shipment and pharmacy-processing status together. A request concerning future payments is also separate from the prescriber's advice about continuing, changing or stopping medication.

For package concerns, Sprout asks for notice within twenty-four hours of delivery for contents, condition or temperature issues, with order details and photographs. It gives forty-eight hours for a package marked delivered but missing. A later passage uses a forty-eight-hour heading and a seventy-two-hour qualification, so the reporting language is not fully consistent. Replacements after confirmed delivery are reviewed case by case, rather than guaranteed. The policy also favors fulfilling a delayed order when supply returns over refunding shortages. Obtain the applicable terms and direct medicine-stability questions to the clinician or dispensing pharmacist. Administrative replacement rules do not establish whether an individual product can be used.

Privacy has implications beyond opting out of promotional email. Sprout's website policy describes account identifiers, device activity, analytics, marketing and service providers, with retention for stated legal or operational purposes. It points protected medical information in authenticated patient interactions toward a separate clinical notice. That notice describes uses for treatment, payment and operations and requests about records and confidential communications. Site assurances and the public terms use different compliance wording; none supplies an independent security assessment. Ask which organization receives a particular request and where sensitive information belongs. Account deletion, marketing preferences and clinical-record rights are different processes, with possible retention exceptions.

Sprout received FDA's 2025 letter concerning compounded semaglutide and tirzepatide marketing that implied approval. Today's homepage expressly distinguishes compounded medicines from approved products. That disclosure does not establish resolution of the letter; a current response or close-out remains unverified.

Sprout's offer is easiest to assess with a complete agreement for the selected billing term, a named clinical and pharmacy arrangement, and written renewal and cancellation details. Compare Emerge Weight Loss, Strut Health and Zealthy on those same responsibilities. Sprout also advertises a separate NAD+ service, which should not be counted as included weight care or treated as a substitute for a clinically appropriate obesity treatment. Existing customers may have different portal instructions and plan terms from new applicants. The financial comparison remains incomplete until the actual charge, supplied period and remaining commitment are clear.